Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6181 AL 6195

Long-term treatment with lithium alleviates memory deficits and reduces amyloid-β production in an aged Alzheimer's disease transgenic mouse model

Zhang X, Heng X, Li T, Li L, Yang D, Zhang X, Du Y, Doody RS, Le W.

J Alzheimers Dis. 2011;24(4):739-49. doi: 10.3233/JAD-2011-101875.

A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease

Burns A, Perry E, Holmes C, Francis P, Morris J, Howes MJ, Chazot P, Lees G, Ballard C.

Dement Geriatr Cogn Disord. 2011;31(2):158-64. doi: 10.1159/000324438. Epub 2011 Feb 19.

Supporting autobiographical memory in patients with Alzheimer's disease using smart phones

De Leo G, Brivio E, Sautter SW.

Appl Neuropsychol. 2011 Jan;18(1):69-76. doi: 10.1080/09084282.2011.545730.

[Early onset Alzheimer's disease - diagnosis, therapy and management]

Natale B, Wohlrab D, Förtsch B, Kurz A, Diehl-Schmid J.

Fortschr Neurol Psychiatr. 2011 Mar;79(3):144-51. doi: 10.1055/s-0029-1245811. Epub 2011 Mar 10.

Cognitive intervention response is related to habitual physical activity in older adults

Thiel C, Vogt L, Tesky VA, Meroth L, Jakob M, Sahlender S, Pantel J, Banzer W.

Aging Clin Exp Res. 2012 Feb;24(1):47-55. doi: 10.3275/7569. Epub 2011 Mar 14.

Association between prescription of conventional or atypical antipsychotic drugs and mortality in older persons with Alzheimer's disease

Musicco M, Palmer K, Russo A, Caltagirone C, Adorni F, Pettenati C, Bisanti L.

Dement Geriatr Cogn Disord. 2011;31(3):218-24. doi: 10.1159/000326213. Epub 2011 Apr 6.

Changes in nursing burden following memantine for agitation and aggression in long-term care residents with moderate to severe Alzheimer's disease: an open-label pilot study

Herrmann N, Cappell J, Eryavec GM, Lanctôt KL.

CNS Drugs. 2011 May;25(5):425-33. doi: 10.2165/11588160-000000000-00000.

Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study

Buschert VC, Friese U, Teipel SJ, Schneider P, Merensky W, Rujescu D, Möller HJ, Hampel H, Buerger K.

J Alzheimers Dis. 2011;25(4):679-94. doi: 10.3233/JAD-2011-100999.

Stem cell therapy for Alzheimer's disease

Abdel-Salam OM.

CNS Neurol Disord Drug Targets. 2011 Jun;10(4):459-85. doi: 10.2174/187152711795563976.

Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease

Förster S, Buschert VC, Buchholz HG, Teipel SJ, Friese U, Zach C, la Fougere C, Rominger A, Drzezga A, Hampel H, Bartenstein P, Buerger K.

J Alzheimers Dis. 2011;25(4):695-706. doi: 10.3233/JAD-2011-100996.

Understanding caregiver health behaviors: depressive symptoms mediate caregiver self-efficacy and health behavior patterns

Rabinowitz YG, Saenz EC, Thompson LW, Gallagher-Thompson D.

Am J Alzheimers Dis Other Demen. 2011 Jun;26(4):310-6. doi: 10.1177/1533317511410557. Epub 2011 Jun 1.

A man with severe Alzheimer's disease stops wandering during a picture colouring activity

Lancioni GE, Perilli V, Singh NN, O'Reilly MF, Cassano G.

Dev Neurorehabil. 2011;14(4):242-6. doi: 10.3109/17518423.2011.575439.

Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation

Lott IT, Doran E, Nguyen VQ, Tournay A, Head E, Gillen DL.

Am J Med Genet A. 2011 Aug;155A(8):1939-48. doi: 10.1002/ajmg.a.34114. Epub 2011 Jul 7.

Kamikihi-to (KKT) rescues axonal and synaptic degeneration associated with memory impairment in a mouse model of Alzheimer's disease, 5XFAD

Tohda C, Nakada R, Urano T, Okonogi A, Kuboyama T.

Int J Neurosci. 2011 Dec;121(12):641-8. doi: 10.3109/00207454.2011.602809. Epub 2011 Aug 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias